Skip to content
CityAM
Main navigation
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • Canada BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      ‘Very concerned’: City watchdog scolds motor finance lenders over £9bn redress scheme

      FCA sign

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
    • From our partners
      • The Morning Briefing: SBS x CityAM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Dallas, Boston, New York New Jersey: Inside England’s Fifa World Cup stadiums

      Getty Images logo against a sleek, modern background, representing the influence of media in the business world

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      Glengarry Glen Ross at the Old Vic fails to close

      Glengarry Glen Ross production at Old Vic Theatre showcasing intense business negotiations and dramatic performances

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Latest Paper
Friday 17 January 2014 5:35 am

How a new contact lens will free diabetics from regular blood tests

By: Jeff Misenti

Add as a preferred source on Google

A smart contact lens could be on its way to help diabetics, by entirely replacing the need for regular blood tests.

The lens uses miniaturised sensors and a wireless transmitter to measure the amount of glucose in a patient's tears.

Google X laboratory's device has already gone through a series of clinical research studies – but the final product could take up to be five years to enter the market.

Google X project leader Brian Otis said:

We're testing a smart contact lens that we built that measures the glucose levels in tears using a tiny wireless chip and a miniaturised glucose sensor.

We've had to work really hard to develop tiny, low-powered electronics that operate on low levels of energy and really small glucose sensors.

Google is also in the process of developing LED lights to indicate when glucose levels have crossed certain levels. The company hopes to partner with other firms to develop apps making the measurements taken by the lens available to the user and their doctor.

The number of diabetes sufferers has grown substantially over recent years. There are 382m diabetics worldwide and one in ten is forecast to suffer from the disease by 2035, according to the International Diabetes Federation.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • CityAM Content

Trending Articles

  • Who could be Andy Burnham’s Chancellor? 

  • As it happened: FTSE 100 finishes higher as US-Iran talks progress and Starmer resigns; Space X shares fall after bond sale

  • Starmer will resign, Trump says

  • Kaleb Cooper: Brits don’t care about the price of milk 

  • Ocado to replace founder Steiner as shares plunge 

More from CityAM

  • Clearwater Analytics Unifies Factor Risk Across Portfolio Management and Risk Oversight

    Business Wire
  • Casamigos brings pint-shaped margaritas to London pubs for World Cup

    Life&Style
    Refreshing margaritas with lime wedges and salt-rimmed glasses on a vibrant table setting, perfect for summer gatherings.
  • KBRA Releases Global ABS 2026 Conference: Day 2 Recap

    Business Wire
  • Airspan Networks Joins Oramach and iVent’s ARES Consortium for European Mission-Critical Communications

    Business Wire
  • Lattice to Showcase Industry-Leading FPGA Innovations at FPGA Conference Europe 2026

    Business Wire
  • Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

    Business Wire
  • Smartstream Launches Smart Agents for Back-Office Operations, Proven Across Tier 1 Pilots

    Business Wire
  • Argan, Inc. Declares Regular Quarterly Cash Dividend of $0.50 Per Common Share

    Business Wire

CityAM Canada — business, markets and opinion for Canadian readers.

Sections

  • Business
  • Markets
  • Tech
  • AI
  • Economics
  • Opinion
  • Cities

Company

  • About
  • Contact

Legal

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 CityAM Canada. All rights reserved.
Terms · Privacy · Cookies